FDA To Review Safety Of GSK, BMS Antiretrovirals Abacavir, Didanosine (Medical News Today)
FDA on Thursday announced that it will review the safety of GlaxoSmithKline's antiretroviral drug abacavir and Bristol-Myers Squibb's antiretroviral didanosine, Reuters reports (Richwine, Reuters, 3/27).

FDA deadlines may compromise drug safety by rushing approval (News-Medical-Net)
Many medications are approved by the U.S. Food and Drug Administration on the brink of congressionally mandated deadlines, and those drugs are more likely to face later regulatory intervention than those approved with greater deliberation, researchers at Harvard University have found.